Global Biologics Drug Substance Manufacturing Market to Exhibit Growth at a CAGR of ~11% by 2032 | DelveInsight

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development and production. This upward trend is further supported by advancements in manufacturing...